Navigation
Content
Footer
US
Sandoz Site Directory
Search
Our Work
What We Do
Disease Areas
Quality Generics
Biosimilars
About Us
Who We Are
Where We Do Business
Corporate Responsibility
For Novartis Investors
Contact Us
Doing Business Responsibly
Patients & Customers
Report Side Effects
Product Safety Notices
Information for Customers
Products
News
US Press Releases & News
Media Contacts
Publications
Careers
Job Search
Working at Sandoz US
Diversity & Inclusion
All News
Advanced Search
Basic Search
From Date:
To Date:
Show:
All
Featured News
Media Releases
In the News
Filter By
2016
June
Media Release
/
Jun 20, 2016
Sandoz announces plans for five major global biosimilar launches by 2020
Read More
2015
November
Media Release
/
Nov 12, 2015
Generic medicines saved US healthcare system more than USD 250 billion in 2014 alone
Read More
October
Media Release
/
Oct 26, 2015
IMPORTANT INFORMATION ABOUT TEMOZOLOMIDE CAPSULES (GENERIC)
Read More
Media Release
/
Oct 16, 2015
Sandoz introduces authorized generic version of LESCOL® XL in the US
Read More
Media Release
/
Oct 02, 2015
FDA accepts Sandoz regulatory submission for a proposed biosimilar etanercept
Read More
September
Media Release
/
Sep 03, 2015
Sandoz launches Zarxio™ (filgrastim-sndz), the first biosimilar in the United States
Read More
Media Release
/
Sep 02, 2015
Sandoz launches authorized generic version of EXELON® PATCH
Read More
August
Media Release
/
Aug 10, 2015
Peter Goldschmidt recognized as one of the Top 100 by PharmaVOICE
Read More
July
Media Release
/
Jul 28, 2015
Sandoz launches generic version of Pulmicort Respules®
Read More
Media Release
/
Jul 09, 2015
Sandoz announces agreement with The Medicines Company to launch an authorized generic of ANGIOMAX®
Read More
Pages
« first
‹ previous
…
2
3
4
5
6
next ›
last »
Twitter
Tweet
Facebook
Share
Share
Twitter
Facebook
Pinterest
LinkedIn
Google +
Email
Jump to Comments
Print
Save
You are here
Home
›
News
›
